Health Biotchnology Portfolio Fund Market Value

SBHIX Fund  USD 24.22  0.20  0.82%   
Health Biotchnology's market value is the price at which a share of Health Biotchnology trades on a public exchange. It measures the collective expectations of Health Biotchnology Portfolio investors about its performance. Health Biotchnology is trading at 24.22 as of the 22nd of November 2024; that is 0.82 percent decrease since the beginning of the trading day. The fund's open price was 24.42.
With this module, you can estimate the performance of a buy and hold strategy of Health Biotchnology Portfolio and determine expected loss or profit from investing in Health Biotchnology over a given investment horizon. Check out Health Biotchnology Correlation, Health Biotchnology Volatility and Health Biotchnology Alpha and Beta module to complement your research on Health Biotchnology.
Symbol

Please note, there is a significant difference between Health Biotchnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Biotchnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Biotchnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Health Biotchnology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Health Biotchnology's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Health Biotchnology.
0.00
12/03/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/22/2024
0.00
If you would invest  0.00  in Health Biotchnology on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Health Biotchnology Portfolio or generate 0.0% return on investment in Health Biotchnology over 720 days. Health Biotchnology is related to or competes with Dreyfus Natural, Fidelity Advisor, Firsthand Alternative, Icon Natural, Franklin Natural, and Short Oil. The fund will normally invest at least 80 percent of its total assets in equity securities of U.S More

Health Biotchnology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Health Biotchnology's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Health Biotchnology Portfolio upside and downside potential and time the market with a certain degree of confidence.

Health Biotchnology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Biotchnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Health Biotchnology's standard deviation. In reality, there are many statistical measures that can use Health Biotchnology historical prices to predict the future Health Biotchnology's volatility.
Hype
Prediction
LowEstimatedHigh
23.4324.2225.01
Details
Intrinsic
Valuation
LowRealHigh
23.6324.4225.21
Details
Naive
Forecast
LowNextHigh
22.6823.4724.26
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.9724.1424.32
Details

Health Biotchnology Backtested Returns

Health Biotchnology holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11% return per unit of standard deviation over the last 3 months. Health Biotchnology exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Health Biotchnology's risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (0.58) to validate the risk estimate we provide. The fund retains a Market Volatility (i.e., Beta) of 0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Health Biotchnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Health Biotchnology is expected to be smaller as well.

Auto-correlation

    
  -0.39  

Poor reverse predictability

Health Biotchnology Portfolio has poor reverse predictability. Overlapping area represents the amount of predictability between Health Biotchnology time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Health Biotchnology price movement. The serial correlation of -0.39 indicates that just about 39.0% of current Health Biotchnology price fluctuation can be explain by its past prices.
Correlation Coefficient-0.39
Spearman Rank Test-0.37
Residual Average0.0
Price Variance0.93

Health Biotchnology lagged returns against current returns

Autocorrelation, which is Health Biotchnology mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Health Biotchnology's mutual fund expected returns. We can calculate the autocorrelation of Health Biotchnology returns to help us make a trade decision. For example, suppose you find that Health Biotchnology has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Health Biotchnology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Health Biotchnology mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Health Biotchnology mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Health Biotchnology mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Health Biotchnology Lagged Returns

When evaluating Health Biotchnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Health Biotchnology mutual fund have on its future price. Health Biotchnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Health Biotchnology autocorrelation shows the relationship between Health Biotchnology mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Health Biotchnology Portfolio.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Health Mutual Fund

Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data